ExEm Foam
(Redirected from Air polymer-type A)
What Is ExEm Foam ?[edit | edit source]
ExEm Foam is an ultrasound contrast agent indicated for sono hysterosalpingography.
What are the uses of this medicine?[edit | edit source]
- ExEm Foam is indicated for sono hysterosalpingography to assess fallopian tube patency in women with known or suspected infertility.
How does this medicine work?[edit | edit source]
- ExEm Foam (air polymer-type A) intrauterine foam is formed by mixing the clear Gel [polymer-type A (hydoxyethyl cellulose), glycerin, and purified water] with air and Sterile Purified Water, creating an echogenic contrast agent.
- When visualized with ultrasound, the foam appears echogenic or bright within the fallopian tubes and peritoneal cavity.
Who Should Not Use this medicine ?[edit | edit source]
This medicine cannot be used in:
- In Pregnancy
- Patients with known or suspected lower genital tract inflammation or infection
- Patients who have had a gynecologic procedure within the last 30 days
- Patients with vaginal bleeding
- Patients with known or suspected reproductive tract neoplasia
Is this medicine FDA approved?[edit | edit source]
- It was approved for use in the United States in November 2019.
How should this medicine be used?[edit | edit source]
- Recommended dose is 2 mL to 3 mL of ExEm Foam by intrauterine infusion using a 5-Fr or larger catheter.
- Dose may be repeated in 2 mL to 3 mL increments, as needed, to achieve visualization of the fallopian tubes.
- Maximum total dose is 10 mL .
What are the dosage forms and brand names of this medicine?[edit | edit source]
ExEm Foam is available as intrauterine Foam, single-dose kit containing:
- Syringe A: one syringe with 5 mL clear Gel [polymer-type A (hydoxyethyl cellulose), glycerin and purified water]
- Syringe B: one syringe with 5 mL Sterile Purified Water
- One Combifix Adaptor (coupling device)
What side effects can this medication cause?[edit | edit source]
Common possible side effects of this medicine include:
- pelvic and abdominal pain
- vasovagal reactions and associated symptoms such as nausea and faintness
- post-procedure spotting
What special precautions should I follow?[edit | edit source]
- Confirm that the patient has a negative pregnancy test within the 24 hours before ExEm Foam administration.
- Confirm that the patient is in the pre-ovulatory phase of her menstrual cycle (cycle days 6 through 11).
Can this medicine be used in pregnancy?[edit | edit source]
- ExEm Foam cannot be used in pregnancy due to the potential risk to the fetus from an intrauterine procedure.
Can this medicine be used in children?[edit | edit source]
- The safety and effectiveness of ExEm Foam have not been established in pediatric patients.
What should I know about storage and disposal of this medication?[edit | edit source]
- Store the kit and components at controlled room temperature between 20° to 25°C (68° to 77°F); [see USP Controlled Room Temperature]; excursions permitted at 15° to 30°C (59° to 86°F).
- Do not store in refrigerator.
- Do not freeze.
ExEm Foam Resources | |
---|---|
|
ExEm Foam Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju